Original Article

Paraoxonase and arylesterase activity in bladder cancer

Volume 43 · Issue 2 Publish Date: July 25, 2019
Full Text PDF
DOI
Mehmet Mazhar Utanğaç
Department of Urology, Dicle University School of Medicine, Diyarbakır, Turkey
Ercan Yeni
Department of Urology, Harran University School of Medicine, Şanlıurfa, Turkey
Murat Savaş
Department of Urology, Ministry of Health, Antalya Training and Research Hospital, Antalya, Turkey
Adem Altunkol
Department of Urology, Ministry of Health, Adana Numune Training and Research Hospital, Adana, Turkey
Halil Çiftçi
Department of Urology, Harran University School of Medicine, Şanlıurfa, Turkey
Kemal Gümüş
Department of Urology, Harran University School of Medicine, Şanlıurfa, Turkey
Mehmet Demir
Department of Urology, Harran University School of Medicine, Şanlıurfa, Turkey
Utanğaç, M. M., Yeni, E., Savaş, M., Altunkol, A., Çiftçi, H., Gümüş, K., & Demir, M. (2019). Paraoxonase and arylesterase activity in bladder cancer. Urology Research and Practice, 43(2), 147–151. https://doi.org/10.5152/tud.2017.89411
Full Text Full Text PDF

Abstract

Abstract

Objective: Oxidative stress is the main pathogenetic mechanism in bladder cancer among many other causes. We aimed to investigate whether a potential relationship exists between bladder cancer and the activities of paraoxonase (PON1) and arylesterase (ARE) enzymes.

Material and methods: The study included 56 patients with bladder cancer, and 57 healthy individuals. The relationships between enzyme activity and tumour grade, stage, muscular invasion and tumour size were evaluated. For statistical analysis, One-Sample Kolmogorov-Smirnov, Independent-T, ANOVA and Post-Hoc Bonferroni tests were used.

Results: Serum levels of PON1 and ARE enzymes, and total cholesterol were significantly lower in bladder cancer group. While other lipid parameters were similar in both the patient and the control groups. Levels of ARE were positively correlated with lipid parameters except for HDL cholesterol.

Conclusion: Our results showed that decreased serum PON1 and ARE enzyme activities are related with tumour load and recurrence. Further studies with larger samples are needed to confirm predictive role of enzymatic activities of PON1 and ARE in the diagnosis and prognosis of bladder cancer.

Similar Articles

Article Info
Published In
Journal Urology Research and Practice
Volume / Issue Volume 43 · Issue 2
Pages 147-151
History
Published Online July 25, 2019
Copyright
Affiliations
Mehmet Mazhar Utanğaç
Department of Urology, Dicle University School of Medicine, Diyarbakır, Turkey
Ercan Yeni
Department of Urology, Harran University School of Medicine, Şanlıurfa, Turkey
Murat Savaş
Department of Urology, Ministry of Health, Antalya Training and Research Hospital, Antalya, Turkey
Adem Altunkol
Department of Urology, Ministry of Health, Adana Numune Training and Research Hospital, Adana, Turkey
Halil Çiftçi
Department of Urology, Harran University School of Medicine, Şanlıurfa, Turkey
Kemal Gümüş
Department of Urology, Harran University School of Medicine, Şanlıurfa, Turkey
Mehmet Demir
Department of Urology, Harran University School of Medicine, Şanlıurfa, Turkey
Cite this Article
Utanğaç, M. M., Yeni, E., Savaş, M., Altunkol, A., Çiftçi, H., Gümüş, K., & Demir, M. (2019). Paraoxonase and arylesterase activity in bladder cancer. Urology Research and Practice, 43(2), 147–151. https://doi.org/10.5152/tud.2017.89411
Outlines